Governing Pharmaceutical Biotechnology Innovation in South Korea
6 Conclusions and final considerations
This research was motivated by a general dissatisfaction with existing conceptualisations o f the adaption o f latecomer innovation systems to the globalisation o f technological innovation. In our research we developed a perspective on how the accommodation o f the advances o f biotechnology research in Korea's industrial structure operates as a driving factor behind the institutional reshaping o f the post-War developmental state model. We departed from the assumption that the configuration o f national institutional arrangements is strongly influenced by historical contingencies. Therefore it is difficult to transfer the Korean experience to other latecomers that are undergoing a transition from a developmental state to an innovation state. Although other late developers are facing similar coordination challenges in overcoming the specific entry barriers o f industrial sectors in which dynamics are shaped by the global spread o f science-driven technologies, there is only limited scope for replicating Korea's transition to a post-developmental state in other historically grown institutional environments. In other words, there is no single silver bullet to switch towards an innovation state. System reconfiguration is a co-evolutionary transformative process that requires coherent changes in several different regards, both in terms of policies and governance and in terms o f systemic linkages. The analysis revealed several aspects that may inform the development of a general framework on post catch-up system change. From the governance of pharmaceutical biotechnology as a disruptive technology (Christensen, 1997) we can derive several conclusions about the multi-faceted transformative dynamics o f a latecomer...
You are not authenticated to view the full text of this chapter or article.
This site requires a subscription or purchase to access the full text of books or journals.
Do you have any questions? Contact us.Or login to access all content.